Separation of metronidazole, its major metabolites and their conjugates using dynamically modified silica
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Separation of metronidazole, its major metabolites and their conjugates using dynamically modified silica. / Thomsen, U. G.; Cornett, Claus; Tjornelund, J.; Hansen, S. H.
In: Journal of Chromatography A, Vol. 697, No. 1-2, 1995, p. 175-184.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Separation of metronidazole, its major metabolites and their conjugates using dynamically modified silica
AU - Thomsen, U. G.
AU - Cornett, Claus
AU - Tjornelund, J.
AU - Hansen, S. H.
PY - 1995
Y1 - 1995
N2 - Metronidazole has previously been used as a probe when investigating cytochrome P450 isoenzymes and thus the pattern of metabolism of this drug has been extensively studied. However, in previous investigations the conjugates were determined by indirect methods. In this paper we present a high-performance liquid chromatographic (HPLC) system for the simultaneous determination of metronidazole, its major metabolites and their glucuronic acid conjugates in biological fluids. The separation is performed using bare silica dynamically modified with N-cetyl-N,N,N-trimethylammonium bromide contained in the mobile phase. The separation of the acidic metabolites of metronidazole is greatly improved with this system compared to other published reversed-phase HPLC systems intended for the same purpose. Glucuronides of metronidazole and its hydroxy metabolites have been synthesized in vitro using rat liver microsomes and preparative HPLC. The method developed makes it possible to determine the intact glucuronic acid conjugates of metronidazole and the hydroxy metabolite in human urine.
AB - Metronidazole has previously been used as a probe when investigating cytochrome P450 isoenzymes and thus the pattern of metabolism of this drug has been extensively studied. However, in previous investigations the conjugates were determined by indirect methods. In this paper we present a high-performance liquid chromatographic (HPLC) system for the simultaneous determination of metronidazole, its major metabolites and their glucuronic acid conjugates in biological fluids. The separation is performed using bare silica dynamically modified with N-cetyl-N,N,N-trimethylammonium bromide contained in the mobile phase. The separation of the acidic metabolites of metronidazole is greatly improved with this system compared to other published reversed-phase HPLC systems intended for the same purpose. Glucuronides of metronidazole and its hydroxy metabolites have been synthesized in vitro using rat liver microsomes and preparative HPLC. The method developed makes it possible to determine the intact glucuronic acid conjugates of metronidazole and the hydroxy metabolite in human urine.
KW - performance liquid-chromatography human-plasma tinidazole assay urine liver feces
M3 - Journal article
VL - 697
SP - 175
EP - 184
JO - Journal of Chromatography
JF - Journal of Chromatography
SN - 0301-4770
IS - 1-2
ER -
ID: 38062337